Rhineland-Palatinate development bank ISB takes stake in 3D cell model startup CAVIGEN

• Investitions- und Strukturbank Rheinland-Pfalz (ISB) invested in CAVIGEN, a Rülzheim-based life-sciences startup, via its venture capital subsidiaries.
• CAVIGEN’s CaviSphere platform enables production and analysis of 3D cell models designed to replicate human tissue more realistically.
• The system uses microstructured films to support cell growth, measuring and controlling oxygen levels directly in the cell environment.
• Funding targets scaling manufacturing from the research phase, positioning the technology for broader use in drug development and personalized medicine.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Investitionsund Strukturbank Rheinland-Pfalz ISB published the original content used to generate this news brief on September 29, 2026, and is solely responsible for the information contained therein.